MIGRAINE AND MODERN APPROACHES TO THERAPY
Keywords:
migraine, headache disorders, CGRP pathwayAbstract
Migraine is one of the most common primary neurological disorders characterized by recurrent attacks of severe headache accompanied by autonomic and neurological symptoms. According to the World Health Organization, migraine is among the leading causes of disability worldwide. The disease significantly affects the quality of life and working capacity of patients. Recent advances in neuroscience have improved the understanding of migraine pathophysiology and led to the development of new therapeutic strategies. In particular, medications targeting the calcitonin gene-related peptide (CGRP) pathway have demonstrated high effectiveness in migraine prevention. This article reviews modern concepts of migraine epidemiology, pathogenesis, clinical manifestations, diagnostic criteria, and contemporary pharmacological and non-pharmacological approaches to migraine therapy.
References
1. Gusev E.I., Skvortsova V.I. Neurology: National Guidelines. Moscow, 2020.
2. Tabeeva G.R. Migraine and Other Headaches. Moscow, 2019.
3. Osipova V.V. Headache in Clinical Practice. Moscow, 2021.
4. Silberstein S.D. Migraine pathophysiology and treatment. Neurology, 2018.
5. Dodick D.W. Migraine. Lancet, 2018.
6. Goadsby P.J. Pathophysiology of migraine. Annals of Neurology, 2019.
7. Ashina M. Migraine and the CGRP pathway. Lancet Neurology, 2021.
8. Charles A. The pathophysiology of migraine. Nature Reviews Neurology, 2018.
9. Lipton R.B. Migraine epidemiology. Headache Journal, 2020.
10. Steiner T.J. Migraine management. Journal of Neurology, 2019.
11. Buse D.C. Burden of migraine. Neurology, 2020.
12. Diener H.C. Migraine treatment guidelines. Cephalalgia, 2019.
13. Edvinsson L. CGRP and migraine therapy. Brain Research Reviews, 2017.
14. Ferrari M.D. Triptans in migraine therapy. Neurology, 2018.
15. Marmura M.J. Acute migraine treatment. Headache, 2020.
16. May A. Chronic migraine. Nature Reviews Neurology, 2018.
17. Olesen J. International classification of headache disorders. Cephalalgia, 2018.
18. Rizzoli P. Preventive treatment of migraine. Neurology Clinics, 2019.
19. Tepper S.J. CGRP monoclonal antibodies in migraine prevention. Headache, 2021.
20. Dodick D.W. Advances in migraine therapy. New England Journal of Medicine, 2020.
21. Ashina H. Migraine treatment strategies. Lancet Neurology, 2022.
22. Stovner L.J. Global burden of migraine. Neurology, 2018.
23. Bigal M.E. Migraine prevention research. Neurology, 2019.
24. Kelman L. Migraine triggers and prevention. Neurology, 2019.
25. Lipton R.B. Global burden of headache disorders. Neurology, 2021.
